Results 261 to 270 of about 692,160 (279)
Some of the next articles are maybe not open access.

Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment

Current Opinion in Chemical Biology, 2021
Trever G Bivona   +2 more
exaly  

Allosteric inhibitors of thrombin

Postdoc Journal, 2013
openaire   +1 more source

ATP-competitive and allosteric inhibitors induce differential conformational changes at the autoinhibitory interface of Akt1

Structure, 2023
Thomas A Leonard   +2 more
exaly  

Allosteric Inhibitors

1973
openaire   +1 more source

Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity

Bioorganic and Medicinal Chemistry Letters, 2009
Tony Siu   +2 more
exaly  

Allosteric p38 kinase inhibitors

Expert Opinion on Therapeutic Patents, 2006
openaire   +1 more source

Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors

ACS Medicinal Chemistry Letters, 2019
Nathanael Gray   +2 more
exaly  

Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity

Angewandte Chemie - International Edition, 2019
Lena Quambusch   +2 more
exaly  

Identification of thieno[3,2-]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase

Bioorganic and Medicinal Chemistry Letters, 2006
Frank Narjes, Uwe Koch, Michael Rowley
exaly  

Pyridine compounds as allosteric SHP2 inhibitors

2018
GILL ADRIAN   +6 more
openaire   +5 more sources
3. good health
humans
allosteric regulation
allosteric site
protein kinase inhibitors
models, molecular
medicine
enzyme inhibitors
animals
previous   25  26  27  28  

Home - About - Disclaimer - Privacy